EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment Pharmaceutical Technology - 27 Feb 2024 EMA CHMP recommends AstraZeneca's Voydeya for PNH treatment ... More
EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer Pharmaceutical Technology Magazine - 08 Mar 2024 EMA Validates Parallel Applications for Datopotamab Deruxtecan in Two Types of Cancer ... More
AstraZeneca Admits In Court Docs Covid Vaccine Can Cause RARE Side Effect, But What Does This Mean? MSN - 29 Apr 2024 AstraZeneca Admits In Court Docs Covid Vaccine Can Cause RARE Side Effect, But What Does This Mean? ... More
Viewpoint: EU pharma reform will stifle innovation, says AstraZeneca's Stefan Woxström Science Business - 26 Oct 2023 Viewpoint: EU pharma reform will stifle innovation, says AstraZeneca's Stefan Woxström ... More
EMA awards double validation for Daiichi Sankyo and AstraZeneca's cancer ADC GlobalData - 05 Mar 2024 EMA awards double validation for Daiichi Sankyo and AstraZeneca's cancer ADC ... More
AstraZeneca and Daiichi Sankyo's Dato-DXd validated by EMA for lung and breast cancer treatment DirectorsTalk Interviews - 04 Mar 2024 AstraZeneca and Daiichi Sankyo's Dato-DXd validated by EMA for lung and breast cancer treatment ... More
EMA validates Daiichi Sankyo-AstraZeneca's cancer therapy applications Pharmaceutical Business Review - 04 Mar 2024 EMA validates Daiichi Sankyo-AstraZeneca's cancer therapy applications ... More
EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks FRANCE 24 English - 16 Mar 2021 EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks ... More
AstraZeneca's Danicopan Among Four Orphans Up For EU Approval Decision Pink Sheet - 19 Feb 2024 AstraZeneca's Danicopan Among Four Orphans Up For EU Approval Decision ... More
EMA Launches Review of Clot Risk With AstraZeneca COVID Vaccine Medscape - 12 Mar 2021 EMA Launches Review of Clot Risk With AstraZeneca COVID Vaccine ... More
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA The Scientist - 08 Apr 2021 Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA ... More
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small ... Business Wire - 04 Mar 2024 Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small ... ... More
EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect' BBC.com - 07 Apr 2021 EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect' ... More
Covid-19: Several EU countries suspend use of AstraZeneca vaccine after patients 'develop blood clots' News24 - 11 Mar 2021 Covid-19: Several EU countries suspend use of AstraZeneca vaccine after patients 'develop blood clots' ... More
European Medicines Agency: AstraZeneca Vaccine Safe - Benefits Outweigh Risks - Despite Possible Rare Events Health Policy Watch - 18 Mar 2021 European Medicines Agency: AstraZeneca Vaccine Safe - Benefits Outweigh Risks - Despite Possible Rare Events ... More
EU regulator ‘convinced’ AstraZeneca benefit outweighs risk Al Jazeera English - 16 Mar 2021 EU regulator ‘convinced’ AstraZeneca benefit outweighs risk ... More
AstraZeneca: EMA says blood clots 'very rare' side effect DW (English) - 07 Apr 2021 AstraZeneca: EMA says blood clots 'very rare' side effect ... More
EMA CHMP issues positive opinion for AstraZeneca's Soliris Pharmaceutical Technology - 27 Jun 2023 EMA CHMP issues positive opinion for AstraZeneca's Soliris ... More
EMA dismisses thyroid cancer link with anti-obesity GLP-1 receptor agonists Pharmaceutical Technology - 30 Oct 2023 EMA dismisses thyroid cancer link with anti-obesity GLP-1 receptor agonists ... More